Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Gout].

W Gröbner¹, N Zöllner

¹Kreisklinik Balingen, Akademisches Lehrkrankenhaus der Universität Tübingen, Tübinger Str. 30, 72336, Balingen, Germany.

Zeitschrift Fur Rheumatologie

|March 3, 2004

Summary

This summary is machine-generated.

Gout is often caused by familial hyperuricemia. Treatment involves diet, uric acid-lowering drugs, and managing acute attacks with anti-inflammatory medications or colchicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Two forms of familial hypercholesterolemia: differences in cardiovascular risk factors, cardiac and extracardiac atherosclerosis].

Deutsche medizinische Wochenschrift (1946)·2014

Same author

[Physical, physiologic and clinical aspects of the plasma proteins].

Medizinische Monatsschrift. Beihefte·2014

Same author

Theory and clinic of the Rh factor.

Klinische Wochenschrift·2010

Same author

Influence of dietary linoleic acid intake with different fat intakes on arachidonic acid concentrations in plasma and platelet lipids and eicosanoid biosynthesis in female volunteers.

Annals of nutrition & metabolism·2003

Same author

Long-term follow-up of patients with iron deficiency anemia.

Zeitschrift fur Gastroenterologie·2001

Same author

Lipid clinics.

European journal of medical research·1999

Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026

Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026

Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026

Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026

Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026

Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026

See all related articles

Area of Science:

Rheumatology and Nephrology
Metabolic Disorders

Context:

Gout is a common clinical manifestation of familial hyperuricemia.
Understanding the pathogenesis and clinical course of hyperuricemia is crucial.

Purpose:

To describe the pathogenesis, clinical manifestations, diagnosis, and differential diagnosis of hyperuricemia and gout.
To outline current treatment strategies for hyperuricemia and acute gout attacks.
To detail the prophylaxis and treatment of acute uric acid nephropathy.

Summary:

Hyperuricemia, often familial, underlies most gout cases.
Management includes dietary changes and urate-lowering drugs (e.g., allopurinol).
Acute gout flares are treated with NSAIDs, colchicine, or corticosteroids.
Uric acid nephropathy prophylaxis involves hydration, urine alkalinization, and medications like allopurinol or rasburicase.

Related Experiment Videos

Rasburicase is the preferred treatment for established acute uric acid nephropathy.

Impact:

Provides a comprehensive overview for clinicians managing hyperuricemia and gout.
Highlights key therapeutic agents for both chronic management and acute conditions.
Emphasizes preventative strategies for uric acid nephropathy, a serious complication.